Topics

Evaluation Of Pharmacokinetic Interaction of Cilostazol with Metoclopramide after Oral Administration in Human.

07:00 EST 4th November 2019 | BioPortfolio

Summary of "Evaluation Of Pharmacokinetic Interaction of Cilostazol with Metoclopramide after Oral Administration in Human."

Metoclopramide is mainly metabolized by CYP2D6, CYP3A4, CYP2C19, and CYP1A2 enzymes, while cilostazol is also metabolized by CYP3A4, CYP2C19, and CYP1A2 enzymes.

Affiliation

Journal Details

This article was published in the following journal.

Name: Current drug metabolism
ISSN: 1875-5453
Pages:

Links

DeepDyve research library

PubMed Articles [14531 Associated PubMed Articles listed on BioPortfolio]

Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.

Metoclopramide is primarily a dopamine receptor antagonist, with 5HT receptor antagonist and 5HT receptor agonist activity, and used as an antiemetic and gastroprokinetic since almost 50 years. Regul...

Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects.

The quaternary ammonium compound trospium chloride is poorly absorbed from 2 "absorption windows" in the jejunum and cecum/ascending colon, respectively. To confirm whether intestinal P-glycoprotein (...

Cilostazol protects against myocardial ischemia and reperfusion injury by activating transcrption factor EB (TFEB).

Although cilostazol was proved to have anti-tumor biological effects. its function in myocardial ischemia and reperfusion (I/R) injury and the underlying mechanisna were not fully illustrated yet. In ...

The Evolution of Population Pharmacokinetic Model of Oral Phenytoin for Early Seizure Prophylaxis Post-Craniotomy.

This study aimed to re-establish a Population Pharmacokinetic (PPK) model of oral phenytoin to further optimize the individualized medication regimen based on our previous research.

Pharmacokinetic characterization of kalata B1 and related therapeutics built on the cyclotide scaffold.

Oral activity has been described for cyclotide-containing traditional medicines, and demonstrated for reengineered cyclotides bearing grafted therapeutic epitopes, highlighting their potential for tra...

Clinical Trials [9217 Associated Clinical Trials listed on BioPortfolio]

Cilostazol 100 mg Tablet Formulations Under Fasting Conditions

The objective of this randomized, single-dose, two-way evaluation is to compare the bioequivalence of a test cilostazol formulation to an equivalent oral dose of the commercially available...

Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

The study is designed to evaluate the bioequivalency between the test formulations of extended-release tablet of cilostazol (PMR) administered once-daily and the reference formulation of i...

Fasted Bioavailability Study of Cilostazol Tablets, 100 mg

The purpose of this study is to evaluate and compare the relative bioavailability of a test formulation of cilostazol tablets to an equivalent dose of Pletal® (cilostazol) tablets after a...

Fasted Bioavailability Study of Cilostazol Tablets, 50mg

The purpose of this study is to evaluate and compare the relative bioavailability of a test formulation of cilostazol tablets to an equivalent dose of Pletal® (cilostazol) tablets after a...

Effects of Cilostazol on Plasma Adipocytokine and Arterial Stiffness

Cilostazol is an antiplatelet agent used to reduce the symptoms of intermittent claudication. Cilostazol inhibits phosphodiesterase III (PDE III), which causes it to be a vasodilator and i...

Medical and Biotech [MESH] Definitions

A dopamine D2 antagonist that is used as an antiemetic.

Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.

A branch of dentistry dealing with diseases of the oral and paraoral structures and the oral management of systemic diseases. (Hall, What is Oral Medicine, Anyway? Clinical Update: National Naval Dental Center, March 1991, p7-8)

A self-evaluation of health status.

Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.

Quick Search


DeepDyve research library

Searches Linking to this Article